View in EDS

Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

Saved in:
Bibliographic Details
Title: Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.
Authors: Rammant E; End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Ghent, Belgium. Electronic address: elke.rammant@ugent.be., Fox L; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., De Padova S; Psycho-Oncology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori,' Meldola, Italy., Liedberg F; Istitution of Translational Medicine, Lund University, Malmö, Sweden., Wintner LM; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Holzner B; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Aaronson NK; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Beyer K; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Bex A; The Royal Free London NHS Foundation Trust, London, UK; UCL Division of Surgery and Interventional Science, London, UK; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Čapoun O; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Catto JWF; Academic Urology Unit, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Chaloner R; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Costin M; Fight Bladder Cancer, Oxfordshire, UK., Decaestecker K; Department of Urology Maria Middelares General Hospital, Ghent, Belgium., Enting D; Guy's & St. Thomas' NHS Foundation Trust, London, UK., Fonteyne V; Department of Human Structure and Repair, Ghent University, Ghent, Belgium., Hendricksen K; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Amsterdam, the Netherlands., Kachel T; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Kassianos A; Department of Nursing, Cyprus University of Technology, & Cancer Research and Innovation Centre (CARIC), Limassol, Cyprus., Lewis R; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Makaroff L; Fight Bladder Cancer, Chinnor, UK; World Bladder Cancer Patient Coalition, Brussels, Belgium., Morcom E; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Neuzillet Y; Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France., O'Brien T; Department of Urology, Guy's and St. Thomas' National Health Service Foundation Trust, London, UK., Pappot H; Department of Oncology, Copenhagen University Hospital, Copenhagen Ø, Denmark., Philipps L; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK., Richters A; Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands., Ripping DM; Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands., Rouanne M; Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France., Rudman S; Guy's & St. Thomas' NHS Foundation Trust, London, UK., Shrestha S; School of Pharmacy, Monash University, Malaysia., Soukup V; Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Spaas M; Department of Human Structure and Repair, Ghent University, Ghent, Belgium., Sztankay M; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Thomas C; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., van Leeuwen M; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Van Hemelrijck M; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Corporate Authors: EORTC Quality of Life Group
Source: European urology oncology [Eur Urol Oncol] 2026 May 26. Date of Electronic Publication: 2026 May 26.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42191529
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rammant+E%22">Rammant E</searchLink>; End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Ghent, Belgium. Electronic address: elke.rammant@ugent.be.<br /><searchLink fieldCode="AU" term="%22Fox+L%22">Fox L</searchLink>; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22De+Padova+S%22">De Padova S</searchLink>; Psycho-Oncology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori,' Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Liedberg+F%22">Liedberg F</searchLink>; Istitution of Translational Medicine, Lund University, Malmö, Sweden.<br /><searchLink fieldCode="AU" term="%22Wintner+LM%22">Wintner LM</searchLink>; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Holzner+B%22">Holzner B</searchLink>; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Aaronson+NK%22">Aaronson NK</searchLink>; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Beyer+K%22">Beyer K</searchLink>; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Bex+A%22">Bex A</searchLink>; The Royal Free London NHS Foundation Trust, London, UK; UCL Division of Surgery and Interventional Science, London, UK; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Čapoun+O%22">Čapoun O</searchLink>; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Catto+JWF%22">Catto JWF</searchLink>; Academic Urology Unit, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Chaloner+R%22">Chaloner R</searchLink>; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Costin+M%22">Costin M</searchLink>; Fight Bladder Cancer, Oxfordshire, UK.<br /><searchLink fieldCode="AU" term="%22Decaestecker+K%22">Decaestecker K</searchLink>; Department of Urology Maria Middelares General Hospital, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Enting+D%22">Enting D</searchLink>; Guy's & St. Thomas' NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Fonteyne+V%22">Fonteyne V</searchLink>; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Hendricksen+K%22">Hendricksen K</searchLink>; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kachel+T%22">Kachel T</searchLink>; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Kassianos+A%22">Kassianos A</searchLink>; Department of Nursing, Cyprus University of Technology, & Cancer Research and Innovation Centre (CARIC), Limassol, Cyprus.<br /><searchLink fieldCode="AU" term="%22Lewis+R%22">Lewis R</searchLink>; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Makaroff+L%22">Makaroff L</searchLink>; Fight Bladder Cancer, Chinnor, UK; World Bladder Cancer Patient Coalition, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Morcom+E%22">Morcom E</searchLink>; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Neuzillet+Y%22">Neuzillet Y</searchLink>; Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France.<br /><searchLink fieldCode="AU" term="%22O'Brien+T%22">O'Brien T</searchLink>; Department of Urology, Guy's and St. Thomas' National Health Service Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Pappot+H%22">Pappot H</searchLink>; Department of Oncology, Copenhagen University Hospital, Copenhagen Ø, Denmark.<br /><searchLink fieldCode="AU" term="%22Philipps+L%22">Philipps L</searchLink>; Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Richters+A%22">Richters A</searchLink>; Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Ripping+DM%22">Ripping DM</searchLink>; Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Rouanne+M%22">Rouanne M</searchLink>; Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France.<br /><searchLink fieldCode="AU" term="%22Rudman+S%22">Rudman S</searchLink>; Guy's & St. Thomas' NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Shrestha+S%22">Shrestha S</searchLink>; School of Pharmacy, Monash University, Malaysia.<br /><searchLink fieldCode="AU" term="%22Soukup+V%22">Soukup V</searchLink>; Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Spaas+M%22">Spaas M</searchLink>; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Sztankay+M%22">Sztankay M</searchLink>; Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Thomas+C%22">Thomas C</searchLink>; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22van+Leeuwen+M%22">van Leeuwen M</searchLink>; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Van+Hemelrijck+M%22">Van Hemelrijck M</searchLink>; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22EORTC+Quality+of+Life+Group%22">EORTC Quality of Life Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101724904%22">European urology oncology</searchLink> [Eur Urol Oncol] 2026 May 26. <i>Date of Electronic Publication: </i>2026 May 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101724904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2588-9311 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225889311%22">25889311 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42191529
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.euo.2026.04.016
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rammant E
      – PersonEntity:
          Name:
            NameFull: Fox L
      – PersonEntity:
          Name:
            NameFull: De Padova S
      – PersonEntity:
          Name:
            NameFull: Liedberg F
      – PersonEntity:
          Name:
            NameFull: Wintner LM
      – PersonEntity:
          Name:
            NameFull: Holzner B
      – PersonEntity:
          Name:
            NameFull: Aaronson NK
      – PersonEntity:
          Name:
            NameFull: Beyer K
      – PersonEntity:
          Name:
            NameFull: Bex A
      – PersonEntity:
          Name:
            NameFull: Čapoun O
      – PersonEntity:
          Name:
            NameFull: Catto JWF
      – PersonEntity:
          Name:
            NameFull: Chaloner R
      – PersonEntity:
          Name:
            NameFull: Costin M
      – PersonEntity:
          Name:
            NameFull: Decaestecker K
      – PersonEntity:
          Name:
            NameFull: Enting D
      – PersonEntity:
          Name:
            NameFull: Fonteyne V
      – PersonEntity:
          Name:
            NameFull: Hendricksen K
      – PersonEntity:
          Name:
            NameFull: Kachel T
      – PersonEntity:
          Name:
            NameFull: Kassianos A
      – PersonEntity:
          Name:
            NameFull: Lewis R
      – PersonEntity:
          Name:
            NameFull: Makaroff L
      – PersonEntity:
          Name:
            NameFull: Morcom E
      – PersonEntity:
          Name:
            NameFull: Neuzillet Y
      – PersonEntity:
          Name:
            NameFull: O'Brien T
      – PersonEntity:
          Name:
            NameFull: Pappot H
      – PersonEntity:
          Name:
            NameFull: Philipps L
      – PersonEntity:
          Name:
            NameFull: Richters A
      – PersonEntity:
          Name:
            NameFull: Ripping DM
      – PersonEntity:
          Name:
            NameFull: Rouanne M
      – PersonEntity:
          Name:
            NameFull: Rudman S
      – PersonEntity:
          Name:
            NameFull: Shrestha S
      – PersonEntity:
          Name:
            NameFull: Soukup V
      – PersonEntity:
          Name:
            NameFull: Spaas M
      – PersonEntity:
          Name:
            NameFull: Sztankay M
      – PersonEntity:
          Name:
            NameFull: Thomas C
      – PersonEntity:
          Name:
            NameFull: van Leeuwen M
      – PersonEntity:
          Name:
            NameFull: Van Hemelrijck M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 05
              Text: 2026 May 26
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2588-9311
          Titles:
            – TitleFull: European urology oncology
              Type: main
ResultId 1